MaestroClin Limited

The company focuses on "discovery and characterization" of new metabolism-related factors (e.g., FGF21 in their previous studies), from deciphering mechanisms to real life applications in the pharmaceutical industry.  They provide diabetic drug development, contract research services and novel metabolism-related factor discovery pipeline selling to customers from pharmaceutical companies to small start-up biotechnology companies to angel investors.

Team Member(s)

Lo Tak Ho (Department of Health Technology and Informatics)
Chan Ka Yun Duncan (PolyU's friend)
Wong Chi Ming (PolyU's friend)
Wu Mengyao (Department of Health Technology and Informatics)